Shanghai Shyndec Pharmaceutical Co., Ltd.

XSSC:600420 Rapporto sulle azioni

Cap. di mercato: CN¥16.4b

Shanghai Shyndec Pharmaceutical Crescita futura

Future criteri di controllo 1/6

Shanghai Shyndec Pharmaceutical is forecast to grow earnings and revenue by 16% and 7.6% per annum respectively. EPS is expected to grow by 16.1% per annum. Return on equity is forecast to be 10.3% in 3 years.

Informazioni chiave

16.0%

Tasso di crescita degli utili

16.1%

Tasso di crescita dell'EPS

Pharmaceuticals crescita degli utili19.3%
Tasso di crescita dei ricavi7.6%
Rendimento futuro del capitale proprio10.3%
Copertura analitica

Low

Ultimo aggiornamento15 Oct 2024

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Previsioni di crescita degli utili e dei ricavi

XSSC:600420 - Stime future degli analisti e dati finanziari passati (CNY Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/202613,7051,557N/A2,7842
12/31/202512,8761,377N/A2,4902
12/31/202412,0241,173N/A2,2021
9/30/202411,5011,0822,0362,300N/A
6/30/202411,5851,0652,3322,626N/A
3/31/202411,7768441,8802,162N/A
12/31/202312,0706921,3631,720N/A
9/30/202312,4027652,0222,336N/A
6/30/202313,0177482,1862,500N/A
3/31/202313,1327292,4022,708N/A
12/31/202212,9596282,5482,856N/A
9/30/202212,9543631,9242,273N/A
6/30/202212,7003672,1152,503N/A
3/31/202213,2604251,5361,991N/A
12/31/202113,9455681,1581,680N/A
9/30/202113,9036491,1481,712N/A
6/30/202113,9777489661,524N/A
3/31/202113,1827341,4702,002N/A
12/31/202012,5566491,1821,560N/A
9/30/202012,538713153496N/A
6/30/202012,156611-72371N/A
3/31/202012,328607293685N/A
12/31/201912,1996568661,270N/A
9/30/201911,8607032,4182,839N/A
6/30/201911,7236672,3892,779N/A
3/31/201911,3867171,2701,669N/A
12/31/201811,3217061,2701,669N/A
9/30/201810,4166472,2202,530N/A
6/30/20189,791569N/A2,411N/A
3/31/20189,260530N/A2,565N/A
12/31/20178,518516N/A2,315N/A
9/30/20179,086539N/A1,050N/A
6/30/20179,124544N/A869N/A
3/31/20179,324534N/A654N/A
12/31/20169,126477N/A839N/A
9/30/201613,514773N/A1,898N/A
6/30/201612,126697N/A1,821N/A
3/31/201610,388580N/A1,912N/A
12/31/20158,988530N/A1,666N/A
9/30/20152,829206N/A254N/A
6/30/20152,820211N/A50N/A
3/31/20152,882203N/A202N/A
12/31/20142,749190N/A259N/A
9/30/20142,492169N/A292N/A
6/30/20142,442159N/A386N/A
3/31/20142,317137N/A129N/A
12/31/20132,350133N/A207N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: 600420's forecast earnings growth (16% per year) is above the savings rate (2.9%).

Guadagni vs Mercato: 600420's earnings (16% per year) are forecast to grow slower than the CN market (25.8% per year).

Guadagni ad alta crescita: 600420's earnings are forecast to grow, but not significantly.

Ricavi vs Mercato: 600420's revenue (7.6% per year) is forecast to grow slower than the CN market (14% per year).

Ricavi ad alta crescita: 600420's revenue (7.6% per year) is forecast to grow slower than 20% per year.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: 600420's Return on Equity is forecast to be low in 3 years time (10.3%).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y